George Gourzoulidis1, Georgia Kourlaba2, Panagiotis Stafylas3, Gregory Giamouzis4, John Parissis5, Nikolaos Maniadakis6. 1. EVROSTON LP, Chatzigianni Mexi 5, 115 28 Athens, Greece. Electronic address: gourzoulidis.g@evroston.com. 2. Collaborative Center of Clinical Epidemiology and Outcomes Research (CLEO), Non-Profit Civil Partenrship, Athens, Greece. 3. Medical Research & Innovation LP, Thessaloniki, Greece. 4. Department of Cardiology, Larissa University Hospital, Larissa, Greece. 5. Department of Cardiology, Athens University Hospital Attikon, Athens, Greece. 6. Department of Health Services Organization, National School of Public Health, Athens, Greece.
Abstract
OBJECTIVE: To determine the association between copayment, medication adherence and outcomes in patients with Heart failure (HF) and Diabetes Mellitus (DM). METHODS: PubMed, Scopus and Cochrane databases were searched using combinations of four sets of key words for: drug cost sharing; resource use, health and economic outcomes; medication adherence; and chronic disease. RESULTS: Thirty eight studies were included in the review. Concerning the direct effect of copayment changes on outcomes, the scarcity and diversity of data, does not allow us to reach a clear conclusion, although there is some evidence indicating that higher copayments may result in poorer health and economic outcomes. Seven and one studies evaluating the relationship between copayment and medication adherence in DM and HF population, respectively, demonstrated an inverse statistically significant association. All studies (29) examining the relationship between medication adherence and outcomes, revealed that increased adherence is associated with health benefits in both DM and HF patients. Finally, the majority of studies in both populations, showed that medication adherence was related to lower resource utilization which in turn may lead to lower total healthcare cost. CONCLUSION: The results of our systematic review imply that lower copayments may result in higher medication adherence, which in turn may lead to better health outcomes and lower total healthcare expenses. Future studies are recommended to reinforce these findings.
OBJECTIVE: To determine the association between copayment, medication adherence and outcomes in patients with Heart failure (HF) and Diabetes Mellitus (DM). METHODS: PubMed, Scopus and Cochrane databases were searched using combinations of four sets of key words for: drug cost sharing; resource use, health and economic outcomes; medication adherence; and chronic disease. RESULTS: Thirty eight studies were included in the review. Concerning the direct effect of copayment changes on outcomes, the scarcity and diversity of data, does not allow us to reach a clear conclusion, although there is some evidence indicating that higher copayments may result in poorer health and economic outcomes. Seven and one studies evaluating the relationship between copayment and medication adherence in DM and HF population, respectively, demonstrated an inverse statistically significant association. All studies (29) examining the relationship between medication adherence and outcomes, revealed that increased adherence is associated with health benefits in both DM and HF patients. Finally, the majority of studies in both populations, showed that medication adherence was related to lower resource utilization which in turn may lead to lower total healthcare cost. CONCLUSION: The results of our systematic review imply that lower copayments may result in higher medication adherence, which in turn may lead to better health outcomes and lower total healthcare expenses. Future studies are recommended to reinforce these findings.
Authors: Patrick Timpel; Lorenz Harst; Doreen Reifegerste; Susann Weihrauch-Blüher; Peter E H Schwarz Journal: Diabetologia Date: 2019-08-27 Impact factor: 10.122
Authors: Paul A Heidenreich; Gregg C Fonarow; Yekaterina Opsha; Alexander T Sandhu; Nancy K Sweitzer; Haider J Warraich Journal: J Card Fail Date: 2022-01-24 Impact factor: 6.592
Authors: Tracey-Lea Laba; Helen K Reddel; Nicholas J Zwar; Guy B Marks; Elizabeth Roughead; Anthony Flynn; Michele Goldman; Aine Heaney; Kirsty Lembke; Stephen Jan Journal: Pharmacoeconomics Date: 2019-02 Impact factor: 4.981
Authors: Stacy Cooper Bailey; Amisha Wallia; Sarah Wright; Guisselle A Wismer; Alexandra C Infanzon; Laura M Curtis; Samantha A Brokenshire; Arlene E Chung; Daniel S Reuland; Allison J Hahr; Kenneth Hornbuckle; Karen Lockwood; Lori Hall; Michael S Wolf Journal: J Med Internet Res Date: 2019-10-21 Impact factor: 5.428
Authors: Peter E H Schwarz; Patrick Timpel; Lorenz Harst; Colin J Greaves; Mohammed K Ali; Jeffrey Lambert; Mary Beth Weber; Mohamad M Almedawar; Henning Morawietz Journal: J Am Coll Cardiol Date: 2018-10-09 Impact factor: 24.094